Human Genome Sciences Inc. (HGSI) (1 Viewer)

guly

Forumer storico
http://finance.yahoo.com/news/Human-Genome-Sciences-Invites-bw-3986588240.html?x=0&.v=1

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference

Source: Human Genome Sciences, Inc.
On Friday September 4, 2009, 8:00 am EDT

ROCKVILLE, Md. --(BUSINESS WIRE)-- Human Genome Sciences, Inc. (NASDAQ:HGSI - News) announced today that its presentation at the 2009 Thomas Weisel Partners Healthcare Conference will be webcast and may be accessed at www.hgsi.com

member of Human Genome Sciences’ senior management team will present a corporate overview on Wednesday, September 9, 2009 at 10:55 am EDT.

Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.

HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company’s web site at www.hgsi.com

scusa ma a che ora italiana sarebbero le 10.55 edt?
 

magolibero

..se la sà gira..
oggi tocca a QLTI andare sulle montagne russe ?

http://finance.yahoo.com/news/QLT-announces-receipt-of-a-prnews-2363555330.html?x=0&.v=4


QLT announces receipt of a CDN$45.3 million tax refund

Press Release
Source: QLT Inc.
On Tuesday September 8, 2009, 7:30 am ED


VANCOUVER, Sept. 8 /PRNewswire-FirstCall/
- QLT Inc. (NASDAQ: QLTI - News; TSX: QLT - News;

"QLT" or the "Company") today announced that it has received an income tax refund of Cdn$45.3 million from the Canada Revenue Agency.
The income tax refund resulted primarily from a request to carryback losses the Company incurred in 2007 in connection with the judgment of the United States District Court for the District of Massachusetts in favor of Massachusetts Eye and Ear Infirmary.
The amount of the refund, before certain minor adjustments, was reflected in the previously filed financial statements of the Company, including as part of the income tax receivable balance at June 30, 2009. As a result, the tax refund is not expected to have any material effect on the Company's current period statement of operations.
 

coxy

coxy
azzarola ,,,, 3,55 :eek::eek::eek::eek::eek::eek::eek::eek::eek::eek::eek:

e son aumentati anche i volumi ;););)


L'interesse immediato si aticolerà per dicembre, ma ciò che mi intriga è la tecnologia di drug delivery.
Campo ampio, ma una tecnologia validata nell'occhio potrà essere estesa ad altri organi patologie.
Tramite spin off di altre imprese con mission specifiche o per semplice acquisizione da parte di un big pharma? La presenza di pfi-pfi (Fifì per gli intimi) farebbe pensare al piano B.
 

acqua+

ONDA NITRICA
L'interesse immediato si aticolerà per dicembre, ma ciò che mi intriga è la tecnologia di drug delivery.
Campo ampio, ma una tecnologia validata nell'occhio potrà essere estesa ad altri organi patologie.
Tramite spin off di altre imprese con mission specifiche o per semplice acquisizione da parte di un big pharma? La presenza di pfi-pfi (Fifì per gli intimi) farebbe pensare al piano B.


caro COXI ,,,, ieri mi son riguardato tutte le info della/sulla soc. ,,,, :eek::eek::eek:

basta tentennamenti ,,,, oggi si parte all'attacco :D:D:D

,,, e apro un 3d dedicato :up::up:
 

Users who are viewing this thread

Alto